4//SEC Filing
Danziger Asaf 4
Accession 0001562180-23-005755
CIK 0001645113other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:12 PM ET
Size
10.1 KB
Accession
0001562180-23-005755
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Danziger Asaf
Director
Transactions
- Award
Ordinary Shares
2023-06-30$35.28/sh+367$12,948→ 13,989 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2023.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001654435
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:12 PM ET
- Size
- 10.1 KB